Last reviewed · How we verify
Proparacaine Hydrochloride 0.5% Drop — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Proparacaine Hydrochloride 0.5% Drop (Proparacaine Hydrochloride 0.5% Drop) — Retina Vitreous Associates of Florida.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Proparacaine Hydrochloride 0.5% Drop TARGET | Proparacaine Hydrochloride 0.5% Drop | Retina Vitreous Associates of Florida | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Proparacaine Hydrochloride 0.5% Drop CI watch — RSS
- Proparacaine Hydrochloride 0.5% Drop CI watch — Atom
- Proparacaine Hydrochloride 0.5% Drop CI watch — JSON
- Proparacaine Hydrochloride 0.5% Drop alone — RSS
Cite this brief
Drug Landscape (2026). Proparacaine Hydrochloride 0.5% Drop — Competitive Intelligence Brief. https://druglandscape.com/ci/proparacaine-hydrochloride-0-5-drop. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab